However, as cancer advances and cells become refractory to the inhibitory effects of TGFβ, TGFβ can be tumor promoting by stimulating epithelial to mesenchymal transition (EMT), weakening immune surveillance, and enhancing tumor proliferation and chemoresistance36. The gene discussed is TGFB1; the disease is cancer.